Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?

Deuse, T; Schrepfer, S; Pelletier, M P; Fischbein, M P; Robbins, R C; Reichenspurner, H

Deuse, T; Schrepfer, S; Pelletier, M P; Fischbein, M P; Robbins, R C; Reichenspurner, H.

Affiliation

Deuse T; Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany. t.deuse@uke.uni-hamburg.de

Transplant Proc ; 39(2): 569-72, 2007 Mar.

Article in En | MEDLINE | ID: mdl-17362784

Subject(s)

Alkynes/therapeutic use; Graft Rejection/immunology; Graft Survival/immunology; Heart Transplantation/immunology; Immunosuppressive Agents/therapeutic use; Isoxazoles/therapeutic use; Nitriles/therapeutic use; Trachea/transplantation; Transplantation, Homologous/immunology; Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Graft Rejection/prevention & control; Graft Survival/drug effects; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sirolimus/therapeutic use; Tacrolimus/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Trachea / Transplantation, Homologous / Heart Transplantation / Alkynes / Graft Rejection / Graft Survival / Immunosuppressive Agents / Isoxazoles / Nitriles Limits: Animals Language: En Journal: Transplant Proc Year: 2007 Document type: Article

Search on Google

XML

PubMed Links